Literature DB >> 15863273

Amino acid transport system L is differently expressed in human normal oral keratinocytes and human oral cancer cells.

Jung Hoon Yoon1, In Jin Kim, Hyun Kim, Heung-Joong Kim, Moon Jin Jeong, Sang Gun Ahn, Soo A Kim, Chong Heon Lee, Bong Kyu Choi, Jong-Keun Kim, Kyu Yong Jung, Seoul Lee, Yoshikatsu Kanai, Hitoshi Endou, Do Kyung Kim.   

Abstract

Previously, we reported the expression and function of system L amino acid transporter in KB human oral epidermoid carcinoma cells. In the present study, therefore, we investigated the expression and function of system L amino acid transporter in human normal oral keratinocytes (HNOK) and compared the expressions and functions of system L amino acid transporters in HNOK and KB cells. The HNOK expressed L-type amino acid transporter 1 (LAT1) and L-type amino acid transporter 2 (LAT2) with their subunit 4F2hc in the plasma membrane but the expression of LAT1 was very weak, which is in contrast to the KB cells expressing LAT1 but not LAT2 with the 4F2hc in the plasma membrane. The [14C] L-leucine uptake by HNOK, as well as KB cells, was inhibited by the system L selective inhibitor BCH. The majority of [14C] L-leucine uptake was, therefore, mainly mediated by LAT2 in the HNOK and by LAT1 in the KB cells. These results suggest that the transport of neutral amino acids including several essential amino acids into the HNOK and KB cells are mainly mediated by LAT2 and LAT1, respectively. The specific inhibition of LAT1 in oral cancer cells could be a new rationale for anti-cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15863273     DOI: 10.1016/j.canlet.2004.09.040

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer.

Authors:  Delphine Denoyer; Laura Kirby; Kelly Waldeck; Peter Roselt; Oliver C Neels; Thomas Bourdier; Rachael Shepherd; Andrew Katsifis; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-13       Impact factor: 9.236

2.  Tumor suppressor gene adenomatous polyposis coli downregulates intestinal transport.

Authors:  Rexhep Rexhepaj; Anand Rotte; Shuchen Gu; Diana Michael; Venkanna Pasham; Kan Wang; Daniela S Kempe; Teresa F Ackermann; Björn Brücher; Falko Fend; Michael Föller; Florian Lang
Journal:  Pflugers Arch       Date:  2011-03-11       Impact factor: 3.657

3.  Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression.

Authors:  Zhongxing Liang; Heidi T Cho; Larry Williams; Aizhi Zhu; Ke Liang; Ke Huang; Hui Wu; Chunsu Jiang; Samuel Hong; Ronald Crowe; Mark M Goodman; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2010-11-24

4.  Metal based imaging probes of DO3A-Act-Met for LAT1 mediated methionine specific tumors: synthesis and preclinical evaluation.

Authors:  K Ganesh Kadiyala; Anupama Datta; Jyoti Tanwar; Anupriya Adhikari; B S Hemanth Kumar; Krishna Chuttani; Meganathan Thirumal; Anil K Mishra
Journal:  Pharm Res       Date:  2014-09-10       Impact factor: 4.200

5.  Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas.

Authors:  Zhen Haining; Nobuyuki Kawai; Keisuke Miyake; Masaki Okada; Shuichi Okubo; Xiang Zhang; Zhou Fei; Takashi Tamiya
Journal:  BMC Clin Pathol       Date:  2012-02-28

Review 6.  Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.

Authors:  Lorena Pochini; Mariafrancesca Scalise; Michele Galluccio; Cesare Indiveri
Journal:  Front Chem       Date:  2014-08-11       Impact factor: 5.221

Review 7.  Cancer stratification by molecular imaging.

Authors:  Justus Weber; Uwe Haberkorn; Walter Mier
Journal:  Int J Mol Sci       Date:  2015-03-04       Impact factor: 5.923

8.  Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel.

Authors:  Pegah Khosravian; Mehdi Shafiee Ardestani; Mehdi Khoobi; Seyed Naser Ostad; Farid Abedin Dorkoosh; Hamid Akbari Javar; Massoud Amanlou
Journal:  Onco Targets Ther       Date:  2016-12-01       Impact factor: 4.147

9.  The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

Authors:  Rokaya El Ansari; Madeleine L Craze; Islam Miligy; Maria Diez-Rodriguez; Christopher C Nolan; Ian O Ellis; Emad A Rakha; Andrew R Green
Journal:  Breast Cancer Res       Date:  2018-03-22       Impact factor: 6.466

10.  Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle.

Authors:  Thijs Kaper; Loren L Looger; Hitomi Takanaga; Michael Platten; Lawrence Steinman; Wolf B Frommer
Journal:  PLoS Biol       Date:  2007-10       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.